With a lanky, awkward and downright scary delivery, it’s understandable to have concerns about how long Chris Sale‘s body is going to last. The Chicago White Sox made sure to snag Sale to a long-term deal this offseason as the club made a five-year, $32 million commitment to the ace this March.
This was a steal in my eyes, and after the poise that he showed versus the Kansas City Royals on Monday, it’s evident that he is ready to become a full-fledged ace. After the Royals fouled off a 15 foul balls in the first inning, Sale was able to settle down and allowed only one run over 7.2 innings pitched. It looked like another troubling day for Sale after he threw 36 pitches in the first frame, but the 24-year-old was not going to let that ruin his day.
The all-star tied a career-high in pitches on Monday with 119 offerings, so the questions of a weak left arm and the inquiries that his delivery lends injury should be put to a screeching halt.
Oddly enough, MLB is getting to the point where every great pitcher is getting Tommy John surgery early in their careers, and they each come back to the hill bigger and better than before. Sale should avoid the surgery at all costs, but it’s interesting to see such a trend when Tommy John used to be a death sentence.
When the mid-summer classic rolls around, Sale will represent the American League as his stuff is undoubtedly the best on his team and if not for Justin Verlander, he would be the ace of the division.